The Patent Finder

Leo Osprey Limited

Also on record
Records under this name other than patents Leo Osprey Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Leo Osprey Limited

PatentTitleStatus Expires Confidence
US 8,821,927Pharmaceutical Composition
now held by Novartis AG
In force
 · High confidence
In forceHigh confidence
US 9,278,099Pazopanib Formulation
now held by Novartis AG
In force
 · High confidence
In forceHigh confidence
US 7,829,297Treatment of Cancers Expressing P95 ERBB2
now held by Novartis AG
Term ended
Term ended Aug 2, 2024 · High confidence
Term endedTerm ended Aug 2, 2024High confidence
US 7,105,530Pyrimidineamines as Angiogenesis Modulators
now held by Novartis AG
Term ended
Term ended Oct 19, 2023 · High confidence
Term endedTerm ended Oct 19, 2023High confidence
US 7,141,576Cancer Treatment Method
now held by Novartis AG
Term ended
Term ended Mar 10, 2022 · High confidence
Term endedTerm ended Mar 10, 2022High confidence
US 8,444,988Cancer Treatment Method
now held by Novartis AG
Term ended
Term ended Jan 14, 2022 · Medium confidence
Term endedTerm ended Jan 14, 2022Medium confidence
US 7,262,203Pyrimidineamines as Angiogenesis Modulators
now held by Novartis AG
Term ended
Ended no later than Dec 19, 2021 · Medium confidence
Term endedEnded no later than Dec 19, 2021Medium confidence
US 7,858,626Pyrimidineamines as Angiogenesis Modulators
now held by Novartis AG
Term ended
Term ended Dec 19, 2021 · High confidence
Term endedTerm ended Dec 19, 2021High confidence
US 8,114,885Chemical Compounds
now held by Novartis AG
Term ended
Ended no later than Dec 19, 2021 · Medium confidence
Term endedEnded no later than Dec 19, 2021Medium confidence
US 7,157,466Quinazoline Ditosylate Salt Compounds
now held by Novartis AG
Term ended
Term ended Nov 19, 2021 · High confidence
Term endedTerm ended Nov 19, 2021High confidence
10 of 26 records shown.
Pro members see all 26.
Pro members: see all 26 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited